The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
JAZZ · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
LYRA · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
ENDV · Healthcare · No moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | JAZZ | LYRA | ENDV | NKTR |
|---|---|---|---|---|
| Moat Score (0–100) | 39 (highest) | 39 (highest) | 39 (highest) | 39 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 62 (highest) | 57 | 15 | 25 |
| Pricing power | — | — | 70 | 87 (highest) |
| Returns on capital | 28 (highest) | 0 | — | 4 |
| Balance-sheet safety | 28 | 55 (highest) | 28 | 55 (highest) |
| Capital allocation | 39 | 44 (highest) | 44 (highest) | 24 |
| No price data | No price data | No price data | No price data | |
| Market cap | $15.6B | $922939 | $21323 | $1.4B |
| Moat tier | No moat | No moat | No moat | No moat |
| Filing date | FY2025 | FY2025 | FY2022 | FY2025 |